GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Mesalamine Delayed Release Tablets USP 1200mg (Meslataj-DR)
B. Mesalamine Delayed Release Tablets USP 800mg (Meslataj-DR)
C. Mesalamine Delayed Release Tablets USP 400mg (Meslataj-DR)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Mesalamine Delayed Release Tablets USP 1200mg
Each film-coated delayed release tablet contains:
Mesalamine USP …………………1200mg
Excipients……………………………..q.s.
Colour: Iron Oxide Red and Ferric Oxide Red USP-NF


B. Mesalamine Delayed Release Tablets USP 800mg
Each film-coated delayed release tablet contains:
Mesalamine USP …………………800mg
Excipients………………………………q.s.
Colour: Iron Oxide Red and Ferric Oxide Red USP-NF

C. Mesalamine Delayed Release Tablets USP 400mg
Each film-coated delayed release tablet contains:
Mesalamine USP …………………400mg
Excipients……………………………..q.s.
Colour: Iron Oxide Red and Ferric Oxide Red USP-NF

THERAPEUTIC INDICATIONS:

Mesalamine is used to treat and prevent flare-ups of mild to moderately active ulcerative colitis (an inflammatory bowel disease). It works inside the bowels to reduce inflammation and other symptoms of the disease. They are indicated for the maintenance of remission of ulcerative colitis in adults. The safety and effectiveness of Asacol for the maintenance of remission of ulcerative colitis in pediatric patients have not been established.

CAUTION & WARNING:

CAUTION: TABLET SHOULD BE SWALLOWED WHOLE & DO NOT CHEWED OR CRUSHED.
WARNING: To be sold by retail on the prescription of a Specialist/Gastroenterologist.

STORAGE & DOSAGE:

Storage: Store at 25°C. Keep in cool & Dry place. Protect from Light. Do not refrigerate.
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Dosage: As directed by the Physician.

Mesalamine Delayed Release Tablets 1200mg Technical Specification: 

Product Name: Mesalamine Delayed Release Tablets USP
Brand Name: Meslataj-DR
Strength: 1200mg, 800mg, 400mg
Dosage Form: Delayed Release Film-coated Oral Tablets
Route of Administration: Via Oral Route
Packing: 10s, 15s, 50s, 100s
Pack Insert/Leaflet: PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents: COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use: Anti-inflammatory, Gastroenterological
Indication: Mesalamine is used to treat and prevent flare-ups of mild to moderately active ulcerative colitis (an inflammatory bowel disease). They are indicated for the maintenance of remission of ulcerative colitis in adults.
Storage: Store at 25°C. Keep in cool & Dry place. Protect from Light. Do not refrigerate.

GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Mesalamine Delayed Release Tablets USP 1200mg (Meslataj-DR)
B. Mesalamine Delayed Release Tablets USP 800mg (Meslataj-DR)
C. Mesalamine Delayed Release Tablets USP 400mg (Meslataj-DR)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A. Mesalamine Delayed Release Tablets USP 1200mg
Each film-coated delayed release tablet contains:

Mesalamine USP …………………1200mg
Excipients……………………………..q.s.
Colour: Iron Oxide Red and Ferric Oxide Red USP-NF

B. Mesalamine Delayed Release Tablets USP 800mg
Each film-coated delayed release tablet contains:
Mesalamine USP …………………800mg
Excipients………………………………q.s.
Colour: Iron Oxide Red and Ferric Oxide Red USP-NF

C. Mesalamine Delayed Release Tablets USP 400mg
Each film-coated delayed release tablet contains:
Mesalamine USP …………………400mg
Excipients……………………………..q.s.
Colour: Iron Oxide Red and Ferric Oxide Red USP-NF

THERAPEUTIC INDICATIONS:

Mesalamine is used to treat and prevent flare-ups of mild to moderately active ulcerative colitis (an inflammatory bowel disease). It works inside the bowels to reduce inflammation and other symptoms of the disease. They are indicated for the maintenance of remission of ulcerative colitis in adults. The safety and effectiveness of Asacol for the maintenance of remission of ulcerative colitis in pediatric patients have not been established.

CAUTION & WARNING:

CAUTION: TABLET SHOULD BE SWALLOWED WHOLE & DO NOT CHEWED OR CRUSHED.

Warning: To be sold by retail on the prescription of a Specialist/Gastroenterologist.

STORAGE & DOSAGE:

Storage: Store at 25°C. Keep in cool & Dry place. Protect from Light. Do not refrigerate.
Read enclosed leaflet before use.
Keep medicine out of reach of children.

Dosage: As directed by the Physician.

Introduction to Mesalamine Delayed Release Tablets 1200mg

Mesalamine Delayed Release Tablets 1200mg are specialized anti-inflammatory tablets formulated to treat and maintain remission in ulcerative colitis, a chronic inflammatory disease of the colon and rectum that causes pain, diarrhea, and rectal bleeding.

Mesalamine belongs to the class of 5-aminosalicylic acid (5-ASA) anti-inflammatory agents. The delayed-release formulation ensures that the medication reaches the colon intact, maximizing therapeutic benefits and minimizing systemic side effects.

The global demand for Mesalamine 1200mg tablets is growing due to the increasing prevalence of inflammatory bowel diseases (IBD), including ulcerative colitis and Crohn’s ileocolitis. Medical practitioners and distributors worldwide are seeking reliable manufacturers and exporters for consistent supply.

Taj Pharma is a well-recognized Mesalamine Delayed Release Tablets 1200mg manufacturer in India, delivering premium quality products compliant with international pharmaceutical standards.

 Trusted Manufacturer, Exporter, and Supplier

Taj Pharma Ltd, based in Vapi, Gujarat, India, is a leading Mesalamine Delayed Release Tablets 1200mg manufacturer in India. Renowned for high-quality, pure, and reliable pharmaceuticals, Taj Pharma serves hospitals, pharmacies, and distributors worldwide.

Key Benefits of Mesalamine Delayed Release Tablets 1200mg:

  • Reduces symptoms: Controls diarrhea, bleeding, and abdominal discomfort

  • Maintenance therapy: Helps prevent relapses of ulcerative colitis

  • Safe & compliant: WHO-GMP and EU-GMP certified

  • Global readiness: Fully documented for international export


Clinical Use and Administration

Mesalamine Delayed Release Tablets 1200mg are prescribed for:

  • Ulcerative colitis: Treat active disease and maintain remission

  • Crohn’s ileocolitis: Where recommended by healthcare providers

Dosage Guidelines:

  • Take orally with food, as advised by your physician

  • Follow the exact prescribed dose

  • Continue the treatment for the full duration, even if symptoms improve

  • Maintain regular consultations with your doctor to monitor progress

Safety Notes:

  • Common side effects: Nausea, diarrhea, stomach pain, headache, flatulence, vomiting, itching

  • Severe reactions: Swelling of face, lips, tongue, throat, rash, fever, unusual bleeding – seek immediate medical attention

  • Precautions: Inform your doctor about kidney, liver issues, allergies, or other medications


Global Demand and Export Market

Mesalamine Delayed Release Tablets 1200mg have significant global market potential due to the rising prevalence of IBD and the need for long-term maintenance therapy.

Key Export Markets:

  • Europe: Germany, France, UK, Italy, Spain

  • Asia: India, Bangladesh, Philippines, Malaysia, Sri Lanka

  • Middle East: UAE, Saudi Arabia, Oman, Qatar

  • Africa: South Africa, Kenya, Egypt, Nigeria

  • North & Latin America: USA, Canada, Brazil, Mexico


In-Depth Details for Importers and Exporters

Regulatory Documentation Provided

  • WHO-GMP Certificate

  • EU-GMP Certificate

  • Certificate of Pharmaceutical Product (COPP)

  • Certificate of Analysis (COA)

  • Certificate of Origin (COO)

  • Free Sale Certificate

  • CTD/DMF Dossier

  • Stability & batch testing reports

Custom Packaging & Labeling

  • Available in blister packs, bottles, and strips

  • Private labeling and PCD franchise support

  • Export-compliant packaging ensures safe delivery worldwide

Shelf-Life, Storage, and Dosage Form

  • Form: Delayed-release tablet, 1200mg

  • Shelf-Life: 24–36 months

  • Storage: Store below 30°C, away from moisture and direct sunlight

Export Certifications

  • WHO-GMP, EU-GMP, ISO 9001:2015

  • COPP, COA, CTD/DMF dossiers included

  • ICH-compliant stability studies for international market standards


Why Taj Pharma is the Most Trusted Manufacturer and Exporter

1. State-of-the-Art Manufacturing

Taj Pharma uses advanced WHO-GMP-certified facilities with modern machinery to ensure precision, consistency, and high-quality production of Mesalamine Delayed Release Tablets 1200mg.

2. Affordable Pricing with Quality Assurance

Offers competitive pricing while maintaining strict quality control, making it the ideal choice for domestic and global distributors.

3. Global Presence and Supply Chain Support

  • Timely delivery to 40+ countries

  • Comprehensive logistics and regulatory support

  • Reliable international supply chain management

4. Top Export Destinations

  • Europe, Asia, Middle East, Africa, North & Latin America

  • Ensuring access to both emerging and developed markets


Technical Product Specification Table

Specification Details
Product Name Mesalamine Delayed Release Tablets 1200mg
Active Ingredient Mesalamine 1200mg
Dosage Form Delayed-release tablet
Therapeutic Category Anti-inflammatory, Gastrointestinal
Manufacturer Taj Pharma Ltd
Country of Origin India
Packaging Blister packs, bottles, strips
Storage Below 30°C, away from moisture
Shelf Life 24–36 months
Certifications WHO-GMP, EU-GMP, ISO 9001:2015
Documentation COPP, COA, CTD/DMF, Stability Data
Labeling Customizable for global markets
Export Markets Europe, Asia, Middle East, Africa, North & Latin America

Call to Action – Partner with Taj Pharma Today

Distributors, importers, and PCD franchise partners seeking a reliable Mesalamine Delayed Release Tablets 1200mg manufacturer in India can benefit from:

  • WHO-GMP-certified quality

  • Complete regulatory documentation

  • Competitive pricing and consistent supply

  • Timely international delivery

Contact Taj Pharma:
📍 Address: Taj Pharma Ltd, Vapi, Gujarat, India
🌐 Website: www.tajpharma.com
📧 Email: info@tajpharma.com
📞 Phone: +91 74 0000 9975


Top 20 FAQs  

  1. What is Mesalamine 1200mg used for?
    Treats ulcerative colitis and maintains remission.

  2. Who manufactures it in India?
    Taj Pharma Ltd, Vapi, Gujarat.

  3. Dosage form and strength?
    Delayed-release tablet, 1200mg Mesalamine.

  4. How should it be taken?
    With food, exactly as prescribed.

  5. Can it be used long-term?
    Yes, under medical supervision.

  6. Common side effects?
    Nausea, diarrhea, abdominal pain, headache, flatulence, vomiting, itching.

  7. Severe allergic reactions?
    Swelling of face, lips, tongue, throat, rash, fever, unusual bleeding – seek immediate medical attention.

  8. Storage conditions?
    Store below 30°C, away from moisture.

  9. Shelf life?
    24–36 months.

  10. Private labeling available?
    Yes, for PCD franchise and distributors.

  11. Certifications provided?
    WHO-GMP, EU-GMP, ISO 9001:2015.

  12. Can it be exported?
    Yes, globally.

  13. Documentation included?
    COPP, COA, CTD/DMF, stability data.

  14. Target export countries?
    Europe, Asia, Middle East, Africa, North & Latin America.

  15. Is it safe during pregnancy?
    Only under physician supervision.

  16. Can it interact with other medicines?
    Yes, consult a doctor.

  17. Can it be used for Crohn’s disease?
    Yes, if prescribed.

  18. How to handle missed doses?
    Take as soon as remembered; do not double the next dose.

  19. Lifestyle considerations?
    Follow dietary and medical advice.

  20. How to become a PCD partner?
    Contact Taj Pharma via email or phone.